Reference
Food and Drug Administration (FDA). Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of One Lot of Firvanq (Vancomycin Hydrochloride for Oral Solution), Vancomycin 50 mg/mL Kit, Due to a Mix-Up of the Diluent Included in the Kit. Internet Document : 8 Sep 2021. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-one-lot-firvanqr-vancomycin
Rights and permissions
About this article
Cite this article
Azurity's vancomycin oral solution, Firvanq, recalled due to incorrect diluent. Reactions Weekly 1873, 1 (2021). https://doi.org/10.1007/s40278-021-02424-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-02424-6